US4578263A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical pellet
Assignee: Castex Products Ltd
•
Filing: 1984-10-16
•
Granted: 1986-03-25
•
Expires: 2004-10-16
Abstract
Abstract A pellet for administration into and reside in the rumeno-reticular sac of a ruminant and to release successive doses of an active agent, such as an anthelmentic, comprises an assembly (10) of discs (12) each having a peripheral skirt (14) on one side and an inwardly-spaced skirt (16) on the other so that such discs can interfit by said skirts (14, 16) and define therebetween cavities (18) each containing a respective active agent dose (24). A weighting slug (20) is provided at one end of the assembly (10) which is enclosed except at one end by a surrounding plastics sheath (26) so that rumen juices may attack and erode the successive discs (12) to release the successive doses (24). The discs (12) are of a magnesium-based alloy and the slug (20) is of a Zinc-based alloy.
Inventors
- 👤 Derek J. Whitehead
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 19:12
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0068; A61J; A61J3/00; A61J3/06; A61M; A61M31/00; A61M31/002
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
87 words
A pharmaceutical pellet of the kind intended to be administered to a ruminant to reside in its rumeno-reticular sac and release predetermined quantities of biologically-active substance over an extended period of time characterised in that it comprises an assembly consisting of a plurality of plates, of a magnesium alloy, axially spaced to define cavities therebetween, a biologically-active substance in each said cavity, and a retaining water-impermeable sleeve or sheath protecting the assembly from attack by rumen juices except at one axial end or both axial ends thereof.
Claim 2
Dependent Claim
87 words
A pharmaceutical pellet of the kind intended to be administered to a ruminant to reside in its rumeno-reticular sac and release predetermined quantities of biologically-active substance over an extended period of time characterised in that it comprises an assembly consisting of a plurality of plates, of a magnesium alloy, axially spaced to define cavities therebetween, a biologically-active substance in each said cavity, and a retaining water-impermeable sleeve or sheath protecting the assembly from attack by rumen juices except at one axial end or both axial ends thereof.
Claim 3
Dependent Claim
28 words
A pharmaceutical pellet according to claim 1 further characterised in that a weighting slug is incorporated approximately at the middle or at one axial end of the assembly.
Claim 4
Dependent Claim
21 words
A pharmaceutical pellet according to claim 2 wherein the weighting plug is at one end and is enclosed by the sleeve.
Claim 5
Dependent Claim
36 words
A pharmaceutical pellet according to claim 1 wherein each plate is in the form of a disc, the biologically-active substance being present as tablets one of which is present between each adjacent pair of said discs.
Claim 6
Dependent Claim
23 words
A pharmaceutical pellet according to claim 2 wherein a further said tablet is provided between the weighting slug and the endmost disc thereadjacent.
Claim 7
Dependent Claim
65 words
A pharmaceutical pellet according to claim 1 wherein each plate has on one face a first peripheral skirt or flange and on its other face a second skirt inwardly-spaced from its periphery, the second and first skirts respectively of adjacent said discs locating the one within the other to define respective cavities each of which accommodates a respective dose or filling of said active substance.
Claim 8
Dependent Claim
23 words
A pharmaceutical pellet according to claim 6 wherein said second and first skirts are a tight interference fit the one within the other.
Claim 9
Dependent Claim
17 words
A pharmaceutical pellet according to claim 1 wherein the sleeve or sheath is of a plastics material.
Claim 10
Dependent Claim
34 words
A pharmaceutical pellet according to claim 1 which has one axial end only thereof exposed, said exposed end containing a dose of the active agent exposed for immediate delivery upon administration of the pellet.
Claim 11
Dependent Claim
45 words
A pharmaceutical pellet according to claim 1 wherein the magnesium alloy of the plates contains 0 to 15% Aluminium, from 0 to 6% Copper, from 0 to 5% Zinc, from 0 to 25% Nickel and from 0 to 0.5% Cobalt, the percentages being by weight.
Claim 12
Dependent Claim
19 words
A pharmaceutical pellet according to claim 2 wherein the weighted slug is of iron or of a Zinc-based alloy.
Claim 13
Independent Claim
71 words
The method of administering to a ruminant predetermined doses of biologically active substances at predetermined intervals which comprises introducing into the reticulum of a ruminant a device formed by encapsulating doses of two different biologically active substances in successive alternate layers within an insoluble sleeve closed at one end and open at the other such that alternate doses and intermediate doses are successively exposed to rumen juices exclusively of each other.
Claim 14
Independent Claim
71 words
The method of administering to a ruminant predetermined doses of biologically active substances at predetermined intervals which comprises introducing into the reticulum of a ruminant a device formed by encapsulating doses of two different biologically active substances in successive alternate layers within an insoluble sleeve closed at one end and open at the other such that alternate doses and intermediate doses are successively exposed to rumen juices exclusively of each other.
Claim 15
Independent Claim
84 words
The method of administering into a fluid environment predetermined doses of biologically active substances at predetermined intervals which comprises introducing into said fluid environment a device formed by encapsulating doses of two different biologically active substances in successive alternate layers within an open-ended insoluble sleeve in an order such that one of the two biologically active substances is exposed at one end of the sleeve and the other of the two biologically active substances is exposed at the other open end of the sleeve.
Claim 16
Independent Claim
84 words
The method of administering into a fluid environment predetermined doses of biologically active substances at predetermined intervals which comprises introducing into said fluid environment a device formed by encapsulating doses of two different biologically active substances in successive alternate layers within an open-ended insoluble sleeve in an order such that one of the two biologically active substances is exposed at one end of the sleeve and the other of the two biologically active substances is exposed at the other open end of the sleeve.
Claim 17
Independent Claim
72 words
The method of administering into a fluid environment predetermined doses of biologically active substances at predetermined intervals which comprises introducing into said fluid environment a device formed by encapsulating doses of two different biologically active substances in successive alternate layers within an open-ended insoluble sleeve in an arrangement such that one of the two biologically active substances is exposed at each open end exclusively of the other of said biologically active substances.
Claim 18
Independent Claim
72 words
The method of administering into a fluid environment predetermined doses of biologically active substances at predetermined intervals which comprises introducing into said fluid environment a device formed by encapsulating doses of two different biologically active substances in successive alternate layers within an open-ended insoluble sleeve in an arrangement such that one of the two biologically active substances is exposed at each open end exclusively of the other of said biologically active substances.
References Cited (Backward Citations)
US3056724A
Cited
US3594469A
Cited
US3567818A
Cited
CA942667A
Cited
US3964438A
Cited
GB1603970A
Cited
GB2020181A
Cited
US4308250A
Cited
WO1982000094A1
Cited
US4381780A
Cited
GB2115073A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-03-24 | 1989-09-23 | 1990-03-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-03-24 | 1993-09-23 | 1994-03-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-03-24 | 1997-09-23 | 1998-03-25 | $7700.00 | Window Closed / Lapsed |